Dexamethasone and Impetigo - a phase IV clinical study of FDA data

Summary:

Impetigo is reported as a side effect among people who take Dexamethasone (dexamethasone), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Neulasta, and have Glioblastoma multiforme.

The phase IV clinical study analyzes which people have Impetigo when taking Dexamethasone. It is created by eHealthMe based on reports of 161,257 people who have side effects when taking Dexamethasone from the FDA, and is updated regularly.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 161,927 Dexamethasone users. Check the latest studies of Dexamethasone.

What is Impetigo?

Impetigo (contagious skin infection) is found to be associated with 332 drugs and 453 conditions by eHealthMe. Check the latest studies of Impetigo.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

161,257 people reported to have side effects when taking Dexamethasone.
Among them, 73 people (0.05%) have Impetigo.

Among these 73 people:

How long have people been on Dexamethasone when they have Impetigo? *

What is the gender of people who have Impetigo when taking Dexamethasone? *

female: 37.14 %
male: 62.86 %

What is the age of people who have Impetigo when taking Dexamethasone? *

What are other drugs people take besides Dexamethasone? *

What are other side effects people have besides Impetigo? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 43 people, 58.90%
Confusional State: 38 people, 52.05%
Bleeding Into The Skin: 38 people, 52.05%
Cytokine Storm (over-protective immune response that can actually be fatal): 36 people, 49.32%
Delirium (wild excitement): 36 people, 49.32%
Body Temperature Increased: 35 people, 47.95%
Dermatitis Allergic (inflammation of the skin due allergic reaction): 31 people, 42.47%
Pain: 13 people, 17.81%
Fever: 12 people, 16.44%
Back Pain: 12 people, 16.44%

What are the existing conditions these people have? *

Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 28 people, 38.36%
Nausea And Vomiting: 15 people, 20.55%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 8.22%
Insomnia (sleeplessness): 6 people, 8.22%
Pain: 6 people, 8.22%
Oropharyngeal Pain: 6 people, 8.22%
Breast Cancer Metastatic: 5 people, 6.85%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 5.48%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 4.11%
Bronchial Hyperreactivity: 3 people, 4.11%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and have Impetigo?

- Check whether Impetigo is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dexamethasone:

Dexamethasone (161,927 reports)

Impetigo treatments and more:

Impetigo (2,385 reports)

Browse all side effects of Dexamethasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impetigo:

Impetigo (332 drugs)

Browse all the conditions that are associated with Impetigo:

Impetigo (453 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Dexamethasone) and Dexamethasone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.